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Introduction
Intraarticular injections are commonly used in children
with JIA to induce prompt relief of symptoms of active
synovitis, and obtain disease remission as sole therapy or
in combination with systemic treatment. In the recent
years, the wider use of musculoskeletal ultrasound
allowed to detect more precisely the exact site of inflam-
mation and showed to be a safe guide for injection proce-
dures also in tendons sheaths and periarticular tissue.
Objectives
The aim of the study was to investigate the role of
intraarticular steroid injections and injection of tendon
sheaths in the management of children with JIA in a
pediatric rheumatology tertiary care center in the recent
years.
Methods
The charts of all the patients with JIA that underwent to
steroid injection of joints and/or tendon sheaths from
January 2012 to April 2014 in our center were reviewed.
Demographic and clinical data at the time of the steroid
injections were registered, including ongoing therapy and
decision to start a new systemic treatment. In the follow-
up visits, remission of synovitis in the injected sites was
clinically defined as the absence of swelling and/or pain
on motion/tenderness associated to limited joint
restriction.
Results
From January 2012 to April 2014 we performed 181 ster-
oid injection sessions in 145 JIA patients. 25 patients
(17%) underwent to more than one session: 51 sessions
were conducted under local anesthesia, while 130 under
general sedation. In 65 sessions only one joint or tendon
sheath was injected; 2 injections were performed in 51
sessions; 3 or more injections in the same session were
conducted in 75 sessions. The total number of sites
injected was 456, 71 of which (16%) were represented by
tendon sheaths or cysts. After a median period of 4,9
months 79% of the sites injected were in clinical remis-
sion. Of the 21% of sites with persistent synovitis at the
first follow-up visit, 50% achieved remission without add-
ing new treatments after a median of 7 months from the
procedure, while 25% achieved remission only after the
introduction of new systemic treatments; the remaining
25% were not in complete remission at the last follow-up
visit yet.
Conclusion
Intraarticular and tendon sheaths injections in our cen-
ter have been extensively performed in the recent years
for the treatment of synovitis in one or multiple joint
areas in children with JIA. Further longitudinal studies
including imaging definition of remission should be per-
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